AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Inocras closes $31 million in Series B-3 financing to accelerate U.S. commercial expansion.
PRIVATEAug 03, 2026
Amount Raised
$31 Million
Round Type
Series B
San DiegoBiotechnologyHealth CareGenetics
Description
Inocras has successfully closed an oversubscribed Series B-3 financing round, raising $31 million. This funding will be utilized to support the company's commercial expansion efforts in the U.S. market. The round demonstrates strong investor confidence in Inocras's growth strategy and potential.
Company Information
Company
Inocras & Summit Pharmaceuticals International Corporation
Location
San Diego, California, United States
About
Inocras Inc. and Summit Pharmaceuticals International Corporation are collaborating to bring advanced whole genome sequencing (WGS) and bioinformatics services to Japan's healthcare system, aiming to better understand and treat genetic conditions, especially cancer.
Fundz sees it the moment Inocras & Summit Pharmaceuticals International Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
Inocras & Summit Pharmaceuticals International Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
San DiegoBiotechnologyHealth CareGenetics